Sanofi-GSK

    • EU closer to securing 200m doses of Johnson & Johnson Covid-19 vaccine

      EU closer to securing 200m doses of Johnson & Johnson Covid-19 vaccine

      The European Commission is closer to secure 200m doses of a possible vaccine against Covid-19, it announced on Thursday. The Commission has concluded exploratory talks with Janssen Pharmaceutica, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, in a step towards an advance purchase agreement, European Commission President Ursula von der Leyen and Health Commissioner Stella Kyriakides said.

      138